Australia markets close in 3 hours 31 minutes
  • ALL ORDS

    7,703.80
    -3.40 (-0.04%)
     
  • ASX 200

    7,399.70
    -5.70 (-0.08%)
     
  • AUD/USD

    0.7169
    +0.0000 (+0.00%)
     
  • OIL

    72.61
    +0.25 (+0.35%)
     
  • GOLD

    1,784.50
    -1.00 (-0.06%)
     
  • BTC-AUD

    70,325.66
    -640.09 (-0.90%)
     
  • CMC Crypto 200

    1,319.24
    +14.12 (+1.08%)
     
  • AUD/EUR

    0.6321
    +0.0004 (+0.06%)
     
  • AUD/NZD

    1.0531
    +0.0001 (+0.01%)
     
  • NZX 50

    12,776.96
    -91.36 (-0.71%)
     
  • NASDAQ

    16,394.34
    +68.67 (+0.42%)
     
  • FTSE

    7,337.05
    -2.85 (-0.04%)
     
  • Dow Jones

    35,754.75
    +35.32 (+0.10%)
     
  • DAX

    15,687.09
    -126.81 (-0.80%)
     
  • Hang Seng

    24,168.41
    +171.54 (+0.71%)
     
  • NIKKEI 225

    28,840.17
    -20.45 (-0.07%)
     

Progyny (NASDAQ:PGNY) shareholder returns have been solid, earning 122% in 1 year

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really flourishing, you can make more than 100%. For example, the Progyny, Inc. (NASDAQ:PGNY) share price had more than doubled in just one year - up 122%. And in the last month, the share price has gained 15%. Progyny hasn't been listed for long, so it's still not clear if it is a long term winner.

The past week has proven to be lucrative for Progyny investors, so let's see if fundamentals drove the company's one-year performance.

View our latest analysis for Progyny

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

Progyny went from making a loss to reporting a profit, in the last year.

When a company is just on the edge of profitability it can be well worth considering other metrics in order to more precisely gauge growth (and therefore understand share price movements).

However the year on year revenue growth of 65% would help. We do see some companies suppress earnings in order to accelerate revenue growth.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

earnings-and-revenue-growth
earnings-and-revenue-growth

We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. So it makes a lot of sense to check out what analysts think Progyny will earn in the future (free profit forecasts).

A Different Perspective

Progyny boasts a total shareholder return of 122% for the last year. That's better than the more recent three month gain of 2.4%, implying that share price has plateaued recently. It seems likely the market is waiting on fundamental developments with the business before pushing the share price higher (or lower). It's always interesting to track share price performance over the longer term. But to understand Progyny better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 3 warning signs with Progyny (at least 1 which is a bit unpleasant) , and understanding them should be part of your investment process.

We will like Progyny better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting